Advanced bladder cancers respond to immunotherapy regardless of gene mutation status ...Middle East

- News
Advanced bladder cancers respond to immunotherapy regardless of gene mutation status
UNC Lineberger researchers and colleagues report a study has demonstrated that patients with advanced bladder cancers whose tumors have a mutated FGFR3 gene respond to immunotherapy in a manner that is similar to patients without that mutation. This discovery runs counter to previous research that suggested FGFR3-mutated bladder cancers should not be treated with immunotherapy.

Hence then, the article about advanced bladder cancers respond to immunotherapy regardless of gene mutation status was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Advanced bladder cancers respond to immunotherapy regardless of gene mutation status )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News